{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52770"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52770","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"ALZHEIMER’S DISEASE MECHANISM AND DRUG DISCOVERY CENTERING ON HYPERPHOSPHORYLATED TAU","abstract":"Thesis (Ph.D.)--Michigan State University. Biochemistry and Molecular Biology - Doctor of Philosophy, 2025","abstract_html":"Thesis (Ph.D.)--Michigan State University. Biochemistry and Molecular Biology - Doctor of Philosophy, 2025","abstract_has_math":false,"creators":["Wang, Kuang-Wei"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Kuo, Min-Hao","Hoogstraten, Charles","Dickson, Alexander","Hong, Heedeok","Parent, Kristin"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-18T18:59:28Z","subjects":["Biochemistry","Molecular biology"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52770","local:Wang_grad.msu_0128D_21760"],"render_values":[{"text":"etd:52770","href":null,"code":true},{"text":"local:Wang_grad.msu_0128D_21760","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/bg39-4d97","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/bg39-4d97","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52770","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Kuo, Min-Hao","Hoogstraten, Charles","Dickson, Alexander","Hong, Heedeok","Parent, Kristin"]},{"key":"dc:creator","label":"Author","values":["Wang, Kuang-Wei"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biochemistry","Molecular biology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52770","local:Wang_grad.msu_0128D_21760","https://doi.org/doi:10.25335/bg39-4d97"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Biochemistry and Molecular Biology - Doctor of Philosophy, 2025","Misfolding of hyperphosphorylated tau, a microtubule-associated protein, is a hallmark of Alzheimer’s disease (AD) and other tauopathies. However, the mechanisms underlying tau-induced neurotoxicity remain unclear. In this study, I investigated the cellular effects of recombinant hyperphosphorylated tau (p-tau), produced via the PIMAX method. Upon uptake, p-tau triggered intracellular calcium elevation, endoplasmic reticulum (ER) stress, unfolded protein response (UPR), leading to apoptosis. Proteomic analysis revealed dysregulated proteins linked to neurodegeneration. These cellular responses could be mitigated by apomorphine, a brain-permeable drug currently used in Parkinson’s treatment. Furthermore, I explored disease-relevant factors, including the frontotemporal dementia–associated P301L tau mutation and various cholesterol metabolites, which modulated p-tau aggregation and toxicity. To identify potential therapeutic inhibitors, Kuo Lab and our collaborators utilized p-tau aggregation and cytotoxicity assays to perform a high-throughput screen (HTS) of 106,000 small molecules. Several compounds emerged as potent inhibitors against both p-tau aggregation and cytotoxicity with good drug-like properties. Medicinal chemistry optimization of the top hits improved biological safety, central nervous system (CNS) exposure, and efficacy, offering promising candidates for tau-targeted therapies. Together, this work uncovers cellular pathways driving p-tau pathology, identifies modulators of tau toxicity, and establishes a foundation for small-molecule drug discovery in AD and other tauopathies.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (201 p.) : ill."]},{"key":"dc:title","label":"Title","values":["ALZHEIMER’S DISEASE MECHANISM AND DRUG DISCOVERY CENTERING ON HYPERPHOSPHORYLATED TAU"]}]}],"canonical_facts":{"dc:contributor":["Kuo, Min-Hao","Hoogstraten, Charles","Dickson, Alexander","Hong, Heedeok","Parent, Kristin"],"dc:creator":["Wang, Kuang-Wei"],"dc:date":["2025"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Biochemistry and Molecular Biology - Doctor of Philosophy, 2025","Misfolding of hyperphosphorylated tau, a microtubule-associated protein, is a hallmark of Alzheimer’s disease (AD) and other tauopathies. However, the mechanisms underlying tau-induced neurotoxicity remain unclear. In this study, I investigated the cellular effects of recombinant hyperphosphorylated tau (p-tau), produced via the PIMAX method. Upon uptake, p-tau triggered intracellular calcium elevation, endoplasmic reticulum (ER) stress, unfolded protein response (UPR), leading to apoptosis. Proteomic analysis revealed dysregulated proteins linked to neurodegeneration. These cellular responses could be mitigated by apomorphine, a brain-permeable drug currently used in Parkinson’s treatment. Furthermore, I explored disease-relevant factors, including the frontotemporal dementia–associated P301L tau mutation and various cholesterol metabolites, which modulated p-tau aggregation and toxicity. To identify potential therapeutic inhibitors, Kuo Lab and our collaborators utilized p-tau aggregation and cytotoxicity assays to perform a high-throughput screen (HTS) of 106,000 small molecules. Several compounds emerged as potent inhibitors against both p-tau aggregation and cytotoxicity with good drug-like properties. Medicinal chemistry optimization of the top hits improved biological safety, central nervous system (CNS) exposure, and efficacy, offering promising candidates for tau-targeted therapies. Together, this work uncovers cellular pathways driving p-tau pathology, identifies modulators of tau toxicity, and establishes a foundation for small-molecule drug discovery in AD and other tauopathies.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (201 p.) : ill."],"dc:identifier":["etd:52770","local:Wang_grad.msu_0128D_21760","https://doi.org/doi:10.25335/bg39-4d97"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Biochemistry","Molecular biology"],"dc:title":["ALZHEIMER’S DISEASE MECHANISM AND DRUG DISCOVERY CENTERING ON HYPERPHOSPHORYLATED TAU"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:28Z"}